A study shows that anti-CTLA4 immunoglobulin G (IgG)-loaded MSN delivers the mAb against immunoregulatory molecule CTLA4, which modifies the host response to the tumor leading to antitumor activity [78]. This evidence concerns the gene CTLA4 and neoplasm.